Tevogen Bio Holdings Inc

NASDAQ:TVGN USA Biotechnology
Market Cap
$20.93 Million
Market Cap Rank
#33051 Global
#10817 in USA
Share Price
$5.17
Change (1 day)
-7.35%
52-Week Range
$0.16 - $7.79
All Time High
$10.00
About

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in phase 1 clinical trial to treat acute SARS-CoV-2 pat… Read more

Tevogen Bio Holdings Inc - Asset Resilience Ratio

Latest as of March 2023: 43.06%

Tevogen Bio Holdings Inc (TVGN) has an Asset Resilience Ratio of 43.06% as of March 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$10.97 Million
Cash + Short-term Investments
Total Assets
$25.47 Million
All company assets
Resilience Assessment
Very High
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Tevogen Bio Holdings Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Tevogen Bio Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $10.97 Million 43.06%
Total Liquid Assets $10.97 Million 43.06%

Asset Resilience Insights

  • Very High Liquidity: Tevogen Bio Holdings Inc maintains exceptional liquid asset reserves at 43.06% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Tevogen Bio Holdings Inc Industry Peers by Asset Resilience Ratio

Compare Tevogen Bio Holdings Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Tevogen Bio Holdings Inc (None–None)

The table below shows the annual Asset Resilience Ratio data for Tevogen Bio Holdings Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points